PerkinElmer Buying BioLegend for $5.25 Billion 
 

The deal is expected to boost PerkinElmer's existing revenue growth and profit margin profile, and add to adjusted earnings a share in the first full year after the closing.

 
Tesla Poised for Record Earnings 
 

Wall Street expects the Silicon Valley electric-car maker to post second-quarter revenue of roughly $11.4 billion, up from $6 billion a year earlier.

 
Aon, Willis Towers Scrap $30 Billion Merger 
 

The Justice Department had alleged the tie-up would lead to higher prices and reduced innovation for U.S. businesses.

 
Boeing's Starliner Set to Launch, Giving Company a Do-Over in Space 
 

NASA needs another way to get to the space station. Friday's test comes after a failed 2019 attempt.

 
Covid-19 Vaccine Pioneer BioNTech Plans New Malaria and Tuberculosis Shots 
 

The German company said it would invest some of the profits from the vaccine it markets with Pfizer into developing shots for malaria and tuberculosis in Africa.

 
Barclays Overtakes Credit Suisse in Investment Banking 
 

The U.K. bank's climb up the ranks is a sign that its long, frustrated push to be a major player is making progress thanks in part to the troubles of its Swiss rival.

 
Retailers Have Back-to-School in the Bag 
 

After a year of on-and-off Zoom schooling, parents have a fair bit of back-to-school shopping to do as children return to classrooms. Retailers will need it.

 
Credit Suisse Settles Spying Case With Ex-Executive Iqbal Khan 
 

The spying scandal is one of a slew of legal and reputational knocks dogging the bank.

 
Activision Blizzard Gender-Bias Suit Shows Videogame Culture Remains a Flashpoint 
 

Seven years after GamerGate, allegations of misconduct toward women who work in the sector persist.

 
Race for Covid-19 Pill Heats Up 
 

Japan's Shionogi has started human trials for a once-a-day drug designed to neutralize the coronavirus in less than a week as Pfizer and Merck carry out later-stage tests.

 
 

(END) Dow Jones Newswires

July 26, 2021 11:00 ET (15:00 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.